Intramural methotrexate therapy for the prevention of neointimal thickening after ballon angioplasty

The Pathogenesis of Atherosclerosis — An Update

1986 • 4,951 citations

Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium.

1983 • 1,441 citations

Restenosis and the proportional neointimal response to coronary artery injury: Results in a porcine model

1992 • 1,166 citations

Restenosis after coronary angioplasty. Potential biologic determinants and role of intimal hyperplasia.

1989 • 935 citations

Aspirin and Dipyridamole in the Prevention of Re-Stenosis after Percutaneous Transluminal Coronary Angioplasty

1988 • 696 citations

Balloon angioplasty. Natural history of the pathophysiological response to injury in a pig model.

1985 • 633 citations

Intimal proliferation of smooth muscle cells as an explanation for recurrent coronary artery stenosis after percutaneous transluminal coronary angioplasty

1985 • 586 citations

Significance of quiescent smooth muscle migration in the injured rat carotid artery.

1985 • 570 citations

The clinical pharmacology of methotrexate.new applications of an old drug

1978 • 561 citations

Endothelial regeneration in the rat carotid artery and the significance of endothelial denudation in the pathogenesis of myointimal thickening.

1975 • 472 citations

Restenosis after balloon angioplasty. A practical proliferative model in porcine coronary arteries.

1990 • 415 citations

Significance of quiescent smooth muscle migration in the injured rat carotid artery.

1985 • 342 citations

Endothelial regeneration. II. Restitution of endothelial continuity.

1979 • 332 citations

Endothelial regeneration. III. Time course of intimal changes after small defined injury to rat aortic endothelium.

1981 • 316 citations

Effect of 18- to 24-hour heparin administration for prevention of restenosis after uncomplicated coronary angioplasty

1989 • 315 citations

Transluminal coronary angioplasty and early restenosis. Fibrocellular occlusion after wall laceration.

1983 • 302 citations

Effect of nifedipine on recurrent stenosis after percutaneous transluminal coronary angioplasty

1986 • 237 citations

Failure of diltiazem to prevent restenosis after percutaneous transluminal coronary angioplasty

1985 • 234 citations

Experimental models of coronary artery restenosis

1992 • 216 citations

The clinical pharmacology of methotrexate

1983 • 213 citations

Inhibition of in vitro vascular endothelial cell proliferation and in vivo neovascularization by low‐dose methotrexate

1989 • 202 citations

Use of a perforated balloon catheter to deliver concentrated heparin into the wall of the normal canine artery

1990 • 180 citations

Restenosis following transluminal angioplasty in experimental atherosclerosis.

1984 • 169 citations

Determinants of restenosis and lack of effect of dietary supplementation with eicosapentaenoic acid on the incidence of coronary artery restenosis after angioplasty

1989 • 167 citations

Discontinuities in the internal elastic lamina: a comparison of coronary and internal mammary arteries.

1985 • 102 citations

The effects of thrombin on bovine aortic endothelial and smooth muscle cells

1990 • 76 citations

Atherosclerotic Yucatan microswine: An animalmodel with high-grade, fibrocalcific, nonfatty lesions suitable for testing catheter-based interventions

1990 • 57 citations

Factors influencing restenosis after coronary angioplasty.

1990 • 57 citations

The intima of human coronary arteries

1989 • 53 citations

Restenosis after percutaneous transluminal coronary angioplasty. A histopathological study using autopsied hearts.

1990 • 43 citations

Thrombin Interactions with Cultured Fibroblasts: Relationship to Mitogenic Stimulation^a

1986 • 39 citations

The early development of intimal thickening of human coronary arteries

1990 • 30 citations

Effect of balloon inflation on smooth muscle cell proliferation in the porcine carotid artery

1990 • 20 citations

Technologic innovation and care of elderly patients with cardiovascular disease: how will the diagnosis-related group system respond?

1990 • 4 citations